CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,362,306 | -52.3% | 427,954 | -26.2% | 0.00% | -50.0% |
| Q2 2023 | $4,953,226 | +56508.3% | 580,003 | -39.1% | 0.00% | -60.0% |
| Q1 2023 | $8,750 | +535.9% | 952,175 | +606.7% | 0.01% | +400.0% |
| Q4 2022 | $1,376 | -100.0% | 134,730 | -67.0% | 0.00% | -75.0% |
| Q3 2022 | $6,013,000 | -37.9% | 408,459 | -54.7% | 0.00% | -33.3% |
| Q2 2022 | $9,684,000 | +662.5% | 902,482 | +666.3% | 0.01% | +500.0% |
| Q1 2022 | $1,270,000 | -66.9% | 117,774 | -34.2% | 0.00% | -50.0% |
| Q3 2021 | $3,832,000 | – | 178,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |